Top Markets
Coin of the day
Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276
Rankning i aktier #505
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Aktiekurs
$7.99
Marknadsvärde
$50.98B
Förändring (1 dag)
1.45%
Förändring (1 år)
-8.42%
Land
CN
Handel Jiangsu Hengrui Medicine Co., Ltd. (600276)

Kategori

Historik för aktiesplit för Jiangsu Hengrui Medicine Co., Ltd. (600276)
Aktien Jiangsu Hengrui Medicine Co., Ltd. (symbol: 600276) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 13, 2026.
En 600276-aktie köpt före Aug 13, 2026 motsvarar nu 0 600276-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter